Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-09-22

FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approves a supplemental application for the spironolactone and hydrochlorothiazide combination from Prasco Laboratories. This action updates the regulatory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone and Hydrochlorothiazide (Spironolactone; Hydrochlorothiazide)

Snippet

SUPPL AP for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE (SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE)